Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

David Neal Franz(Cincinnati Children's Hospital Medical Center), Е. Д. Белоусова, Steven Sparagana(Texas Scottish Rite Hospital for Children), E. Martina Bebin(University of Alabama), Michael Frost(Minnesota Epilepsy Group), Rachel Kuperman, Olaf Witt(German Cancer Research Center), Michael Kohrman(University of Illinois Chicago), J. Robert Flamini(Children's Healthcare of Atlanta), Joyce Y. Wu(University of California, Los Angeles), Paolo Curatolo(University of Rome Tor Vergata), Petrus J. de Vries(University of Cape Town), Vicky Whittemore(National Institutes of Health), Elizabeth A. Thiele(Massachusetts General Hospital), James Ford(Novartis (United States)), Gaurav Shah(Novartis (United States)), Helene Cauwel(Novartis (United States)), David Lebwohl(Novartis (United States)), Tarek Sahmoud(Novartis (United States)), Sergiusz Jóźwiak(Children's Memorial Health Institute)
The Lancet
November 13, 2012
Cited by 784

Abstract


Related Papers

No related papers found

Powered by citation graph analysis